Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Dianthus Therapeutics (DNTH) Asset Utilization Ratio (2022 - 2025)

Dianthus Therapeutics (DNTH) has 4 years of Asset Utilization Ratio data on record, last reported at 0.02 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 19.83% year-over-year to 0.02; the TTM value through Sep 2025 reached 0.02, up 19.83%, while the annual FY2024 figure was 0.02, 4.66% up from the prior year.
  • Asset Utilization Ratio reached 0.02 in Q3 2025 per DNTH's latest filing, down from 0.03 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.03 in Q2 2023 and bottomed at 0.01 in Q4 2022.
  • Average Asset Utilization Ratio over 4 years is 0.02, with a median of 0.02 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: plummeted 66.83% in 2024, then soared 175.75% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then surged by 63.63% to 0.02 in 2023, then soared by 99.66% to 0.03 in 2024, then tumbled by 42.23% to 0.02 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.02 in Q3 2025, 0.03 in Q2 2025, and 0.03 in Q1 2025.